View in EDS

Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.

Saved in:
Bibliographic Details
Title: Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.
Authors: Hackshaw MD; Department of Medical Affairs for Global Medical Affairs, Daiichi Sankyo, Basking Ridge, NJ, USA., Bui CL; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA., Ladner A; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA., Tu N; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA., Islam Z; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA., Ritchey ME; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA., Salas M; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA; CCEB/CPeRT, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA. Electronic address: msalas@dsi.com.
Source: Cancer treatment and research communications [Cancer Treat Res Commun] 2020; Vol. 24, pp. 100189. Date of Electronic Publication: 2020 Jun 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101694651 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-2942 (Electronic) Linking ISSN: 24682942 NLM ISO Abbreviation: Cancer Treat Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32673845
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hackshaw+MD%22">Hackshaw MD</searchLink>; Department of Medical Affairs for Global Medical Affairs, Daiichi Sankyo, Basking Ridge, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Bui+CL%22">Bui CL</searchLink>; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Ladner+A%22">Ladner A</searchLink>; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Tu+N%22">Tu N</searchLink>; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Islam+Z%22">Islam Z</searchLink>; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Ritchey+ME%22">Ritchey ME</searchLink>; Department of Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA.<br /><searchLink fieldCode="AU" term="%22Salas+M%22">Salas M</searchLink>; Department of Epidemiology, Clinical Safety and Pharmacovigilance, Daiichi Sankyo, Basking Ridge, NJ, USA; CCEB/CPeRT, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA. Electronic address: msalas@dsi.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101694651%22">Cancer treatment and research communications</searchLink> [Cancer Treat Res Commun] 2020; Vol. 24, pp. 100189. <i>Date of Electronic Publication: </i>2020 Jun 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101694651 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2468-2942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224682942%22">24682942 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Treat Res Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32673845
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ctarc.2020.100189
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 100189
    Titles:
      – TitleFull: Review of Survival, Safety, and Clinical Outcomes in HER2+ Metastatic Gastric Cancer Following the Administration of Trastuzumab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hackshaw MD
      – PersonEntity:
          Name:
            NameFull: Bui CL
      – PersonEntity:
          Name:
            NameFull: Ladner A
      – PersonEntity:
          Name:
            NameFull: Tu N
      – PersonEntity:
          Name:
            NameFull: Islam Z
      – PersonEntity:
          Name:
            NameFull: Ritchey ME
      – PersonEntity:
          Name:
            NameFull: Salas M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2468-2942
          Numbering:
            – Type: volume
              Value: 24
          Titles:
            – TitleFull: Cancer treatment and research communications
              Type: main
ResultId 1